Register entry

Catalent Germany Eberbach GmBH

Data as of · How to read this entry

Registered sites
0
Active NDC listings
15
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

15

15 active NDC listings: 15 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 15.

Dosage formNDCs
capsule13
capsule, liquid filled2
RouteNDCs
Labeller name on the listingNDCs
catalent germany eberbach gmbh11
catalent germany eberbach gmbh4
Catalogue

Marketed products

15
BrandGeneric nameForm / routeNDC
-Calcitriolcapsule, liquid filled55361-0001DRUG FOR FURTHER PROCESSING
-Calcitriolcapsule, liquid filled55361-0007DRUG FOR FURTHER PROCESSING
-Etoposidecapsule55361-0006DRUG FOR FURTHER PROCESSING
-METYRAPONEcapsule55361-0011DRUG FOR FURTHER PROCESSING
-Midostaurincapsule55361-0016DRUG FOR FURTHER PROCESSING
-Nintedanibcapsule55361-0020DRUG FOR FURTHER PROCESSING
-Nintedanibcapsule55361-0021DRUG FOR FURTHER PROCESSING
-TRETINOINcapsule55361-0028DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0030DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0031DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0032DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0033DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0034DRUG FOR FURTHER PROCESSING
-Talazoparib tosylatecapsule55361-0035DRUG FOR FURTHER PROCESSING
-Tretinoincapsule55361-0029DRUG FOR FURTHER PROCESSING
Enquiry

Common questions

Is Catalent Germany Eberbach GmBH FDA approved?
Catalent Germany Eberbach GmBH holds no registered establishment of its own; 15 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Catalent Germany Eberbach GmBH make?
15 products are listed under Catalent Germany Eberbach GmBH in the openFDA NDC Directory, most often as capsule; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.